You’ve done the research. You’ve watched the before-and-after videos. You’ve asked your doctor, who shrugged and said “it’s your call.” Now you’re staring at a browser full of tabs and you genuinely cannot tell which of these companies is a real clinical program and which is just a landing page with a countdown timer. That’s the problem this list solves.
These picks are editorially independent, not partner-driven. They’re ranked by value clarity, clinical quality, and whether the program holds up when you read the fine print.
1. FormBlends
FormBlends earns the top spot here for a specific reason: it’s one of the few places where compounded semaglutide and tirzepatide sit on the same menu as an extensive catalog of other clinician-supervised peptides. Weight-loss programs, recovery compounds, peptides with nootropic or longevity applications. One intake, one prescriber, one licensed pharmacy filling the order. That structure is genuinely rare.
The pricing is published up front, no quiz required. Semaglutide runs $299 per vial. Tirzepatide is $349. Compare that to Mochi Health‘s compounded semaglutide at roughly $99 per month plus the cost of escalating doses, and the per-vial math is worth doing before you commit. No membership fee stacked on top of the medication cost.
Quality transparency is real here. FormBlends publishes per-product purity data. The tirzepatide batch, for instance, shows 99.3 percent purity confirmed by HPLC testing. That’s not a generic “third-party tested” badge. It’s a number, attached to a specific compound, that you can actually evaluate.
Ships to 47 states. Cold-chain handled on their end. A care team is reachable around the clock.
One honest note: these are compounded medications, not FDA-approved drugs. The human evidence base for some of the non-GLP-1 peptides in the catalog is still mostly preclinical. Know what you’re ordering.
2. Mochi Health
Mochi gets a lot right that most weight-loss telehealth companies ignore. The clinicians are board-certified in obesity medicine, not just general practitioners handed a prescription template. That distinction matters when you hit a plateau or need a dosing adjustment that requires actual clinical reasoning.
Compounded tirzepatide is around $199 per month. Three- and twelve-month commitments lower the cost further. They also work with insurance for branded medications, so if Zepbound coverage comes through for you, the program doesn’t fall apart. Solid ongoing monitoring for a cash-pay model.
3. Hims and Hers
After a March 2026 settlement with Novo Nordisk, Hims and Hers moved new patients off compounded semaglutide entirely. That’s not a criticism, it’s a market reality. What they offer now is branded medication access: Wegovy injectable at roughly $299 per month, oral Wegovy around $249, Zepbound at $399. With commercial insurance and the available savings card, those numbers can drop to nearly zero.
The app is genuinely fast. Onboarding takes minutes. If your insurance situation is good and you want name-brand FDA-approved medication with a polished digital experience, this is a strong fit.
4. Ro Body
Ro separates the membership cost from the medication cost more clearly than most, which makes it easier to understand what you’re actually paying. Membership runs about $149 per month on a rolling basis, or closer to $74 monthly on an annual prepay. Medication is billed separately.
The standout feature is the prior-authorization team. Getting insurance approval for branded GLP-1s is genuinely painful, and Ro handles a meaningful chunk of that friction. For patients who believe insurance coverage is achievable, the PA support alone is worth considering.
5. PlushCare
PlushCare is not a dedicated weight-loss platform. It’s a broader telehealth service that prescribes FDA-approved GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, through standard clinical visits. App membership is about $19.99 per month. Labs, visits, and prescriptions are billed separately.
Same-day appointments are available. It accepts most major insurance plans. For someone who wants a real physician interaction without committing to a specialized obesity program, PlushCare is a functional, lower-overhead entry point.
The best-reviewed GLP-1 programs share one trait: they show you exactly what you’re paying and why. The 2026 FDA scrutiny of compounded GLP-1 marketing pushed a lot of companies to quietly change their offerings without updating their websites. Read the current terms before you pay anything.
*This article is editorial opinion only, not medical advice. Consult a qualified clinician before starting any GLP-1 or peptide program.*
Sources
- FDA (fda.gov): warning letters to compounding facilities and telehealth companies, 2025-2026
- Drugs.com: branded GLP-1 medication pricing and availability
- Examine.com: peptide and supplement evidence summaries
- GoodRx: current cash pricing for Wegovy, Ozempic, Zepbound, Mounjaro
- Verywell Health: telehealth GLP-1 program comparisons
- Cleveland Clinic: obesity medicine and GLP-1 clinical use
- Healthline: compounded semaglutide explainer and safety overview
[internal: placement #1 | structure: Tight curated list, opinionated picks]
